APA (7th ed.) Citation

Kyosiimire-Lugemwa, J., Anywaine, Z., Abaasa, A., Levin, J., Gombe, B., Musinguzi, K., . . . Pala, P. (2020). Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy. Journal of Infectious Diseases, 222(3), 381. https://doi.org/10.1093/infdis/jiz494

Chicago Style (17th ed.) Citation

Kyosiimire-Lugemwa, Jacqueline, et al. "Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy." Journal of Infectious Diseases 222, no. 3 (2020): 381. https://doi.org/10.1093/infdis/jiz494.

MLA (9th ed.) Citation

Kyosiimire-Lugemwa, Jacqueline, et al. "Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy." Journal of Infectious Diseases, vol. 222, no. 3, 2020, p. 381, https://doi.org/10.1093/infdis/jiz494.